Homeostatic regulation of synaptic strength and the safety factor for neuromuscular transmission

Similar documents
Synthesis. Storage. Physiology and Pathophysiology of Neuromuscular Transmission. Release. Action. Inactivation. Myasthenia Gravis Before

Neuromuscular Junction Testing ELBA Y. GERENA MALDONADO, MD ACTING ASSISTANT PROFESSOR UNIVERSITY OF WASHINGTON MEDICAL CENTER

Quantal Analysis Problems

Cellular Bioelectricity

Alterations in Synaptic Strength Preceding Axon Withdrawal

Activity Dependent Changes At the Developing Neuromuscular Junction

Stanley Iyadurai, PhD MD. Assistant Professor of Neurology/Neuromuscular Medicine Nationwide Children s Hospital Myology Course 2015

CHAPTER 44: Neurons and Nervous Systems

What effect would an AChE inhibitor have at the neuromuscular junction?

BIPN100 F15 Human Physiology 1 Lecture 3. Synaptic Transmission p. 1

Neuromuscular Transmission Diomedes E. Logothetis, Ph.D. (Dr. DeSimone s lecture notes revised) Learning Objectives:

SJ Wood and CR Slater. Rachel Armitage

SYNAPTIC TRANSMISSION 1

THE NEUROMUSCULAR JUNCTION IN HEALTH AND DISEASE. Biomedical Seminar Room 3, Thursdays 9:30-11:30

Assessing neuromuscular transmission in mice with Huntington s disease

Synaptic Transmission

Electrodiagnosis of Neuromuscular Junction Disorders

Myasthenia Gravis. Mike Gilchrist 10/30/06

THE NEUROMUSCULAR JUNCTION IN HEALTH AND DISEASE. Biomedical Seminar Room 5, Mondays 9:30-11:30

Spatial Distribution of Calcium Entry Evoked by Single Action Potentials within the Presynaptic Active Zone

Effects of adrenaline on nerve terminals in the superior cervical ganglion of the rabbit

Papers Form and Function: Homeostatic Regulation of the NMJ. Summary

BIONB/BME/ECE 4910 Neuronal Simulation Assignments 1, Spring 2013

Reliability of neuromuscular transmission and how it is maintained

THE NEUROMUSCULAR JUNCTION IN HEALTH AND DISEASE. Biomedical Seminar Room 7, Mondays 9:30-11:30

Synapse Formation. Steven McLoon Department of Neuroscience University of Minnesota

Neuroscience 201A (2016) - Problems in Synaptic Physiology

Medicine, University of Lund, Sweden

Neurons! John A. White Dept. of Bioengineering

NEURONS COMMUNICATE WITH OTHER CELLS AT SYNAPSES 34.3

Neurons Chapter 7 2/19/2016. Learning Objectives. Cells of the Nervous System. Cells of the Nervous System. Cells of the Nervous System

EE 791 Lecture 2 Jan 19, 2015

Synaptic communication

THE NEUROMUSCULAR JUNCTION IN HEALTH AND DISEASE. Practical Exercises: Function and Structure of Neuromuscular Synapses

BIPN140 Lecture 13: Synapse Formation (Synaptogenesis)

Cellular Neurobiology BIPN140

Miniature Excitatory Synaptic Ion Currents in the Earthworm Lumbriterrestris Body Wall Muscles

Is the Stimulation Frequency of the Repetitive Nerve Stimulation Test that You Choose Appropriate?

ANSC (FSTC) 607 Physiology and Biochemistry of Muscle as a Food MOTOR INNERVATION AND MUSCLE CONTRACTION

Structure of a Neuron:

Chapter 8 11/1/2012. Synaptic Components are Ancient. Syncytium or Synapses? Synapse Formation and Function. Early Calcium Spikes

Bernard Katz ( )

Chapter 3 subtitles Action potentials

Anatomy Review. Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (

1) Drop off in the Bi 150 box outside Baxter 331 or to the head TA (jcolas).

Portions from Chapter 6 CHAPTER 7. The Nervous System: Neurons and Synapses. Chapter 7 Outline. and Supporting Cells

Neuroscience with Pharmacology 2 Functions and Mechanisms of Reflexes. Prof Richard Ribchester

Compensatory Contribution of Ca V. 2.3 Channels to Acetylcholine Release at the Neuromuscular Junction of Tottering Mice

2. What is the name of this junction, and where might it be found? (2 points) (Purves et. al., bottom of Fig. 5.1A) (2 points)

The Nervous System. Dr. ZHANG Xiong Dept. of Physiology ZJU School of Medicine.

浙江大学医学院基础医学整合课程 各论 III. The Nervous System. Dr. ZHANG Xiong Dept. of Physiology ZJU School of Medicine

Biol 219 Lec 12 Fall 2016

Making sense of Nerve conduction & EMG

Neurons. Pyramidal neurons in mouse cerebral cortex expressing green fluorescent protein. The red staining indicates GABAergic interneurons.

Function of the Nervous System

Chapter 3 Neurotransmitter release

MYASTHENIA GRAVIS. Mr. D.Raju, M.pharm, Lecturer

Acetylcholine. Neuroscience with Pharmacology 2. Neuromuscular Junction 2: Pharmacology. Quaternary nitrogen. Neuromuscular Junction - Pharmacology

CLINICAL PRESENTATION

photometry on the extruded cytoplasm.

Nerve Muscle Relationship and Neural Muscular Junction Quiz. Remember, you need to know the structure and the function!

Pharmacology of the Neuromuscular Junction (NMJ)

The action potential travels down both branches because each branch is a typical axon with voltage dependent Na + and K+ channels.

Baraa Ayed. Mohammad khatatbeh. 1 P a g e

PHYSIOLOGY AND PATHOPHYSIOLOGY OF NEUROMUSCULAR TRANSMISSION

NEUROMUSCULAR BLOCKING AGENTS

Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions

Synapses and Neurotransmitters

Structure of the striated muscle general properties

Synapses. Excitatory synapses

A NEW STRATEGY TO ESCAPE FROM EXPRESSION LINES V.0

CONGENITAL MYASTHENIC SYNDROMES: PROGRESS OVER THE PAST DECADE

2005b(14): Describe the processes of excitation and contraction within smooth muscle cells Excitation wandering baseline

active zones 6neuromuscular junction/freeze-fracture electron microscopy/acetylcholine release/ca2" channels/autoantibodies)

Neurons, Synapses, and Signaling

Williams, 1953a, b) and of Burke & Ginsborg (1956b) indicate that nerve

DOI: /jphysiol The Physiological Society Rapid Report

PHIARMACOLOGICAL ASPECTS OF NEUROMUSCULAR TRANSMIS-

ENHANCEMENT BY AN ANTAGONIST OF TRANSMITTER RELEASE FROM FROG MOTOR NERVE TERMINALS

Muscle and Neuromuscular Junction. Peter Takizawa Department of Cell Biology

Synaptic transmission

NEURAL TISSUE (NEUROPHYSIOLOGY) PART I (A): NEURONS & NEUROGLIA

TrkB kinase activity maintains synaptic function and structural integrity at adult neuromuscular junctions

Neuromuscular Physiology. Skeletal muscle & Neuromuscular junction

Chapter 7. The Nervous System: Structure and Control of Movement

Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm

Chapter 7. Objectives

The reasoning why it is thought that active axons have a competitive advantage is controversial, but there are hypothesises:

Ameen Alsaras. Ameen Alsaras. Mohd.Khatatbeh

Severely Impaired Neuromuscular Synaptic Transmission Causes Muscle Weakness in the Cacna1a Mutant Mouse Rolling Nagoya

Nervous System. Master controlling and communicating system of the body. Secrete chemicals called neurotransmitters

Chapter 45: Synapses Transmission of Nerve Impulses Between Neurons. Chad Smurthwaite & Jordan Shellmire

Introduction to Neurobiology

Membrane Potentials. (And Neuromuscular Junctions)

ORIGINS, ACQUISITION, AND IMPLICATIONS

Outline. Neuron Structure. Week 4 - Nervous System. The Nervous System: Neurons and Synapses

QUIZ YOURSELF COLOSSAL NEURON ACTIVITY

Muscle Physiology. Introduction. Four Characteristics of Muscle tissue. Skeletal Muscle

amplitude of spontaneous miniature end-plate potentials (m.e.p.p.s).

J. E. ZENGEL and K. L. MAGLEBY From the Department of Physiology and Biophysics, University of Miami School of Medicine, Miami, Florida 33101

Transcription:

The Life Cycle of Neuromuscular Synapses Homeostatic regulation of synaptic strength and the safety factor for neuromuscular transmission 1. Synaptic transmission, safety factor and sizestrength relationships at NMJ 2. Quantal analysis 3. Pathophysiology Synaptic transmission Synaptic recordings from the frog NMJ: B. Katz et al. MEPPs Desaki & Uehara, 1981, J Neurocytol 1,11 1

Transmission electron micrographs of the principal features of neuromuscular synapses. Schwann cell Nerve terminal Motor end-plate Neuromuscular Junction: postsynaptic Pre Basal lamina Post Junctional Fold Synaptic vesicle http://neuromuscular.wustl.edu/musdist/dag2.htm Each nachr contains two α subunits, giving an overall stoichiometry of α 2 βγδ (fetal form) or α 2 βδε (adult form). Each of the subunits contains four hydrophobic transmembrane domains. 2nm 6 nm Fetal Adult 3 nm 2 nm Bovine Muscle 9 nm Xenopus Oocyte γ subunit ε subunit 2 ms Neuromuscular Junction: presynaptic (vesicle proteins) 2, channels End-Plate Current (EPC) End-Plate Potential (EPP) 2 mv http://neuromuscular.wustl.edu/pathol/snare.htm http://www.hhmi.org/research/investigators/sudhof.html 2

Wood & Slater (1997) Desaki & Uehara, 1981 MEPP EPP Quantal analysis P x MEPPs The ʻSafety Factorʼ for transmission = e m m x x! Actual m Wood SJ, Slater CR. The contribution of postsynaptic folds to the safety factor for neuromusculartransmission in rat fastand slow-twitch muscles.j Physiol. 1997 Apr 1;5 ( Pt 1):165-76. PMID: 997941 Threshold m EPPs Stim. Quantal Size: Quantal Content: q = MEPP m = EPP q Threshold 3

Vm 2.5 mv Vm Ch.2 2.5 mv 1 mv Ch.2 31 Keyboard AC mv 1 6 1 mv 5 4 3 2 Ch.2 1 mv 1. ms 1. ms 85 9 95 1 15 11 115 12 125 13 135 14 145 5. ms s Vm 2.5 mv Ch.2 1 mv 1. ms AC mv 1-2 -4-6 -1-8 Ch.2 1 mv 5. ms 19 2 21 22 23 24 25 26 27 28 29 s Factors affecting safety factor for synaptic transmission -Probability of release -Transmitter store size and mobilisation -Cholinesterase activity -ACh receptor density -Muscle fibre diameter and input resistance -Nerve terminal size/strength -Junctional fold density (Na channel density) Synaptic depression EPPs - Facilitation 1 mv 25 ms 5 ms EPPs - Short-term Depression 1 mv Gillingwater 3 ms D. Thomson Synaptic size-strength regulation maintains safety factor nt mf NMJ size and muscle fibre diameter co-vary 1 mv 2 na R in 2 ms MEPPs EPPs Kuno et al., 1971 4

12 end plate area (µm 2 ) 9 6 3 1 2 3 4 5 6 7 fiber diameter (µm) 2 µm 6 4 2 1 ms 1 mv 1 2 3 4 5 6 Occupancy% Harris JB, Ribchester RR. The relationship between end-plate size and transmitter release in normal anddystrophic muscles of the mouse.j Physiol. 1979 Nov;296:245-65.PMID: 23111 Costanzo EM, Barry JA, Ribchester RR. Co-regulation of synaptic efficacy at stable polyneuronally innervated neuromuscular junctions in reinnervated rat muscle. J Physiol. 1999 Dec 1;521 Pt 2:365-74.PMID: 158138 5 4 Quantal Content (variance method) at NMJ of rat HD First EPP Plateau EPP (1Hz) Species Quantal content Frog 2 Frog 3 Rat, mouse 5-75 2 Man 2-3 Rat 1 1 2 3 4 Age Man (Based on Kelly & Roberts, 1977 and Kelly, 1978) The size of NMJ and the extent of junctional folding vary between species 2 Frog Frog Frog 15 Rat Rat 1 5 25 5 75 1 125 15 Synaptic area Rat Man Man Man 5

4 3 2 Ch Quantal Analysis 1-5 mv 5. ms Binomial model: Binomial model: Let: n=3 p=.17 (q=1-p) m=n.p Let: n=3 p=.1 (q=1-p) m=n.p P() =? P(1) =? P(2) =? P(3) =? P() = q 3 P(1) = 3pq 2 P(2) = 3p 2 q P(3) = p 3 P(x) = n! x!(n! x)! p x.q (n! x) Let : x<<n p<<1 Then q (n-x) ~ exp(-np) P(x) = exp(!m). m x Poisson Distribution P() =? P(1) =? P(2) =? P(3) =? x! and n! (n! x)! " n x 6

P(x) = exp(!m). m x Poisson Distribution P() = exp(-m) P(1) = m.exp(-m) P(2) = m 2.exp(-m)/2 P(3) = m 3.exp(-m)/6 x! Frequency 4 3 2 1 Poisson distribution of Quantal Contents of EPPs (n=1 trials) 1 2 3 4 5 6 7 8 9 1 11 12 Quantal content m=1 Poisson distribution of Quantal Contents of EPPs (n=1 trials) Poisson distribution of Quantal Contents of EPPs (n=1 trials) 4 m=2 4 m=3 Frequency 3 2 Frequency 3 2 1 1 1 2 3 4 5 6 7 8 9 1 11 12 Quantal content 1 2 3 4 5 6 7 8 9 1 11 12 Quantal content Poisson distribution of Quantal Contents of EPPs (n=1 trials) Poisson distribution of Quantal Contents of EPPs (n=1 trials) 4 m=4 4 m=5 Frequency 3 2 Frequency 3 2 1 1 1 2 3 4 5 6 7 8 9 1 11 12 Quantal content 1 2 3 4 5 6 7 8 9 1 11 12 Quantal content 7

Methods of quantal analysis: 1. Direct method : m=epp/mepp (better, EPC/MEPPC) 2. Failures method: P()=exp(-m); m=ln(tests/failures) ( for binomial: P()=(1-p) n ) 3. Variance method: m = 1/(C.V.) 2 i.e. m=epp 2 /var(epp) (for binomial: var(m)=npq) Problems - MEPP variance - Non-linear summation - Non-Poisson conditions The Normal (Gaussian) Distribution y = exp(!(x! µ) 2 / 2" 2 ) /(" 2# ) n + P(x) = " exp(!m) mx.- k =1 x!,- 1 %!( x! kx ) 2 (. 2#k$ 2 ' & 2k$ 2 * )/ y (!x 2 ) # % exp $ & 2".25 y = 5.5 2' (µ = ; σ =.5) 1 ' exp (! 3) " 3 x y 15 % ' & ( 1 '! ( x! 1.1k) 2 ( % ' exp # x! $.2 2)k # % 2k.2 2 $ & & ( ( = * % & # # $ $ k = 1 m=3 quanta σ=.2 mv x =1.1mv x Quantal analysis MEPP EPP P x = e"m m x x! MEPPs EPPs Stim. Quantal Size: Quantal Content: q = MEPP m = EPP q 8

Correction Factors Martin (1955): v' = v /(1! v /(E m! E r )! v m = q(1! v! (E m! E r ) v= EPP amplitude q= MEPP amplitude m = quantal content McLachlan & Martin (1981) v' = v /(1! fv(e m! E r ) Where f = an empirically determined ('fudge ) factor For mouse muscle, long fibres: f=.8 For frog muscle, long fibres: f=.55 McLachlan EM, Martin AR. Non-linear summation of end-plate potentials in the frog and mouse. J Physiol. 1981 Feb;311:37-24.PMID: 6267255 For short muscle fibres (e.g. FDB) the correction is unknown, but f=.3 gives a good fit to our data. Methods of quantal analysis: Pathophysiology 1. Direct method : m=epp/mepp (better, EPC/MEPPC) 2. Failures method: P()=exp(-m); m=ln(tests/failures) ( for binomial: P()=(1-p) n ) 3. Variance method: m = 1/(C.V.) 2 i.e. m=epp 2 /var(epp) (for binomial: var(m)=npq) 4. Convolutions; graphical methods (e.g. see Clements & Silver, TINS 23, 15-113.) Note: For all methods except the Failures Method, it is necessary to assess and correct if required for non-linear summation of synaptic potentials. Synaptic currents sum linearly. Myasthenia Gravis Before After edrophonium (Tensilon Test) Case 1 Bilateral ptosis Double vision in all directions Fatiguable weakness Reflexes disappear after exercise Sensation normal 9

Myasthenic Syndrome(LEMS): EMG EPP Pre- and post-synaptic abnormalities have distinctive effects on EPPs Synaptic Depression Normal - Normal presynaptic function Normal quantal content (impaired postsynaptic function) Synaptic Facilitation LEMS EPPs have low quantal content and show facilitation - Impaired presynaptic function Low quantal content (normal postsynaptic function) Myasthenia gravis and LEMS are autoimmune diseases Botulism: Enzymatic LEMS: Ca channelcleavage of SNARE proteins antibodies Summary of electrophysiological changes in Myasthenia Gravis and Myasthenic Syndrome X X X X MG: AChR antibodies (NI=Normal Individual) Congenital Myasthenic Syndromes Summary Neuromuscular junctions operate with a high safetyfactor, secured in part by the endplate-size to fibre diameter ratio. Statistical analysis of synaptic potential amplitudes shows that transmitter release is quantized. Palace & Beeson (28) J Neuroimmunol Defects in transmitter release, sensitivity and sizestrength relationships lead to various ʻmyasthenicʼ syndromes, characterised by significant muscle weakness. 1